And this passage from the paper promises further work the results of which will be worth waiting for:
“Direction for future adaptation of this technology would be best informed through linking wound healing outcomes with tissue-level laboratory-based investigation of the impact of BTM on the cellular milieu of diabetic foot ulcers and our institution is currently undertaking this work.”
I can see a time when there will be a range of different forms/products that BTM will take just in the setting of diabetes related ulceration.
And this passage from the paper promises further work the...
-
- There are more pages in this discussion • 633 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |